11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC. wck2107@cumc.columbia.edu.
William C
WC
Kreisl
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC.
Robin
R
Lawrence
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC.
Emily
E
Page
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC.
Andrew F
AF
Teich
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC.
Deepa S
DS
Subramaniam
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC.
Robert B
RB
Innis
From the Molecular Imaging Branch (W.C.K., E.P., R.B.I.), National Institute of Mental Health, Bethesda, MD; Taub Institute (W.C.K.), Columbia University Medical Center (A.F.T.), New York, NY; and Memory Disorders Program (R.L., R.S.T.) and Lombardi Comprehensive Cancer Center (D.S.S.), Georgetown University, Washington, DC.
R Scott
RS
Turner
D000081:Acetamides / Q000378:metabolism*; D000368:Aged; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000378:metabolism*; D001254:Astrocytoma / Q000000981:diagnostic imaging / Q000378:metabolism*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism*; D002250:Carbon Radioisotopes / Q000378:metabolism; D005260:Female; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods; D011725:Pyridines / Q000378:metabolism*; D018079:Receptors, GABA / Q000378:metabolism*
D000081:Acetamides; D002250:Carbon Radioisotopes; C526798:N-(2-methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide; D011725:Pyridines; D018079:Receptors, GABA; C499229:TSPO protein, human